Here are three quick notes:
1. The panel will take place in New York City at the Waldorf Astoria Hotel on Mon., Feb. 8, 2016, at 9:30 am EST.
2. The panel is titled “Advances in Ophthalmology: Therapies for Saving Sight” and will be moderated by Tony Gibney, managing director at Leerink Partners.
3. Inotek Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other eye diseases.
More articles on healthcare:
Americans don’t think ACA is top issue in 2016 election — 5 things to know
7 things for ASC leaders to know for Monday — Feb. 1, 2016
Bernie Sanders is in good health, physician reports: 5 things to know
